AbbVie (ABBV) Starts Late-Stage Study on Multiple Myeloma Drug
Johnson & Johnson · PHARMACEUTICAL PREPARATIONS · Now $223.51
+1.2% in 3d after detection
Post-detection moves
1h
—
1d
+0.5%
3d
+1.2%
7d
+0.8%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS